Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation in HIV-infected youth with hypovitaminosis D
2011-000593-54Phase 3Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cholecalciferol in human immunodeficiency virus infection (HIV) and Vitamin D deficiency (VDD), sponsored by Luigi Sacco University Hospital. Primary endpoint: Hypovitaminosis D at 12 months. Started Mar 2012; status: active.
02
Drugs
cholecalciferol
03
Conditions
human immunodeficiency virus infection (HIV)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2011-000593-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000593-54.